Tradestie Institutional Equity Comparison Engine
AXNX vs LIVN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LIVN Overall Edge
LIVN Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to LivaNova PLC Ordinary Shares (LIVN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus LIVN at 19.2x Forward P/E and 14.3% operating margin (+9.9% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LIVN sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
LIVN
AXNX N/M vs LIVN 19.2x Fwd P/E
Growth & Margin Winner
LIVN
Op Margin N/A vs 14.3% ยท YoY N/A vs +9.9%
Momentum & Technical Winner
LIVN
1Y +16.9% vs +68.3% ยท 52W Pos 50% vs 81%
Options & Structure Winner
LIVN
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (11th %ile IV)
AXNX
US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap
N/A
1M Return
-26.54%
1Y Return
+16.92%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
LIVN
NASDAQ
LivaNova PLC Ordinary Shares
Electromedical & Electrotherapeutic Apparatus
$90.73
-1.46% 1D
Market Cap
$5.1B
1M Return
+11.64%
1Y Return
+68.3%
Forward P/E
19.2x
Unified AI Score
41.9 / 100
SELL
Tech 31.0
Fund 41.0
Flow 72.0
Mom 26.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AXNX +16.92%
LIVN +68.3%
Spread: +1.88 pp (LIVN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AXNX TTM Op. Margin: N/A
LIVN TTM Op. Margin: 14.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs LIVN. Trailing 12-month operating profitability (AXNX N/A vs LIVN 14.3%) and valuation multiples (AXNX N/M vs LIVN 19.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AXNX | LIVN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $5.1B | Larger Scale | LIVN |
| Trailing P/E Ratio Valuation | N/M | 26.4x | Lower Multiple | LIVN |
| Forward P/E Ratio Valuation | N/M | 19.2x | Lower Multiple | LIVN |
| Revenue Growth (YoY) Growth | N/A | +9.9% | Higher Growth | LIVN |
| Operating Margin (TTM) Profitability | N/A | 14.3% | Higher Margin | LIVN |
| Net Profit Margin Profitability | N/A | 13.0% | Higher Margin | LIVN |
| Return on Equity (ROE) Capital Efficiency | N/A | 15.5% | Higher ROE | LIVN |
| 52-Week Range Position Momentum | 50% ($0โ$1) | 81% ($53โ$99) | Stronger Trend | LIVN |
| Beta / 30D Volatility Risk Regime | N/A | 0.92ฮฒ ยท 66% Vol | Lower Realized Risk | LIVN |
| Unified Institutional Score Composite Signal | 52.1 / 100 (HOLD) | 41.9 / 100 (SELL) | Higher Composite | AXNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AXNX vs LIVN Buy Guide
AXNX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
LIVN
CONSOLIDATION
98d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
11th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AXNX nor LIVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.